于2025年12月19日，本公司作为买方与供应商II及承租人III订立采购协议XX，本公司向供应商II购买租 赁资产XX，购买价款为人民币403.28万元;及本公司作为出租人与承租人III订立融资租赁协议XX，本公 司向承租人III出租租赁资产XX，租赁期为36个月，总租赁款项约为人民币345.26万元，包括融资租赁 本金为人民币322.62万元及融资租赁利息收入(含增值税)约为人民币22.64万元。 智通财经APP讯，中关村科技租赁(01601)发布公告，于2025年12月19日，本公司作为买方与供应商II及 承租人I订立采购协议XIX，本公司向供应商II购买租赁资产XIX，购买价款为人民币198.8万元;及本公 司作为出租人与承租人I订立融资租赁协议XIX，本公司向承租人I出租租赁资产XIX，租赁期为36个 月，总租赁款项约为人民币170.2万元，包括融资租赁本金为人民币159.04万元及融资租赁利息收入(含 增值税)约为人民币11.16万元。 ...

智通财经APP讯，中关村科技租赁(01601)发布公告，于2025年12月19日，公司作为出租人与承租人 III(山西蓝科途新材料科技有限公司)订立融资租赁协议III，据此，出租人将购入承租人III自有租赁资产 III，转让价款为人民币4300万元;及出租人将租赁资产III租回给承租人III，租赁期为36个月，总租赁款 项约为人民币4765.55万元。租赁资产III为锂电隔膜生产线。 ...

Core Viewpoint - Zhongguancun Technology Leasing (01601) has entered into financing lease agreements with two companies, indicating ongoing business activities in the leasing sector and potential revenue generation from these agreements [1] Group 1: Financing Lease Agreements - The company has signed a financing lease agreement with Qinghai Electronic Materials Development Co., Ltd., involving the purchase of leasing asset II for RMB 49 million and a total lease payment of approximately RMB 49.82 million over a 12-month period [1] - The total lease payment includes a principal amount of RMB 49 million and interest income (including VAT) of approximately RMB 0.82 million [1] Group 2: Recent Transactions - In the past twelve months, the company has also entered into a procurement agreement with Huzhou Nord Energy Storage Co., Ltd., purchasing leasing asset I for RMB 23.22 million [1] - The financing lease agreement with Huzhou Nord includes a total lease payment of approximately RMB 25.98 million over a 60-month period, comprising a principal amount of RMB 23.22 million and interest income (including VAT) of approximately RMB 0.28 million [1] Group 3: Asset Valuation - Leasing asset I, which consists of energy storage battery equipment, has a fair value of approximately RMB 23.22 million [1] - Leasing asset II, related to copper foil production equipment, has a book net value of approximately RMB 52.17 million [1]

Group 1 - The company, Zhongguancun Technology Leasing, has entered into a financing lease agreement with Qinghai Electronic Materials Industry Development Co., Ltd., involving the purchase of leasing asset II for RMB 49 million and a leaseback for a term of 12 months, with total lease payments of approximately RMB 49.82 million, including principal and interest income [1] - In the past twelve months, the company has also entered into a procurement agreement with Huzhou Nord Storage New Energy Co., Ltd., purchasing leasing asset I for RMB 23.22 million and leasing it back for a term of 60 months, with total lease payments of approximately RMB 25.98 million, including principal and interest income [1] - Leasing asset I consists of energy storage battery equipment with a fair value of approximately RMB 23.22 million, while leasing asset II consists of copper foil production equipment with a book value of approximately RMB 52.17 million [1]

于2025年12月19日，(i)公司作为买方与供应商II及承租人III订立采购协议XX，据此，公司向供应商II购 买租赁资产XX，购买价款为人民币4,032,800元；及(ii)公司作为出租人与承租人III订立融资租赁协议 XX，据此(其中包括)，公司向承租人III出租租赁资产XX，租赁期为36个月，总租赁款项约为人民币 3,452,601元，包括融资租赁本金为人民币3,226,240元及融资租赁利息收入(含增值税)约为人民币226,361 元。 格隆汇12月19日丨中关村科技租赁(01601.HK)公告，于2025年12月19日，(i)公司作为买方与供应商II及 承租人I订立采购协议XIX，据此，公司向供应商II购买租赁资产XIX，购买价款为人民币1,988,000元； (ii)公司作为出租人与承租人I衡阳市丰宜科技订立融资租赁协议XIX，据此(其中包括)，公司向承租人I 出租租赁资产XIX，租赁期为36个月，总租赁款项约为人民币1,701,986元，包括融资租赁本金为人民币 1,590,400元及融资租赁利息收入(含增值税)约为人民币111,586元。 ...

Core Viewpoint - Zhongguancun (000931.SZ) announced that its subsidiary Beijing Huasu Pharmaceutical Co., Ltd. has received a Notice of Acceptance from the National Medical Products Administration for the application of Oxycodone Hydrochloride Controlled-Release Tablets (10mg) [1] Group 1 - The application for Oxycodone Hydrochloride Controlled-Release Tablets is accepted for marketing, indicating progress in the drug approval process [1] - Oxycodone is a pure opioid receptor agonist, selectively targeting the μ receptor, and is used clinically for treating severe pain that requires long-term opioid therapy [1] - The primary therapeutic effect of Oxycodone is analgesia, which is crucial for patients with pain that cannot be adequately managed by alternative treatments [1]

证券日报网讯 12月19日晚间，中关村发布公告称，公司下属公司北京华素制药股份有限公司取得国家 知识产权局颁发的发明专利证书，发明名称：一种盐酸丁螺环酮的制备方法。 （文章来源：证券日报） ...

中关村(000931.SZ)公告，公司下属公司北京华素制药股份有限公司(简称：北京华素)于近日收到国家药 品监督管理局签发的《受理通知书》，盐酸羟考酮缓释片(规格：10mg)上市许可申请获得受理。 公告显示，盐酸羟考酮缓释片临床上用于治疗严重到需要长期持续、每天按时使用阿片类药物治疗、且 替代治疗不能充分缓解的疼痛。盐酸羟考酮是一种纯阿片受体激动剂，对μ受体具有相对的选择性，在 更高剂量时也能与其它阿片受体结合;羟考酮的主要治疗作用为镇痛。 ...

智通财经APP讯，中关村(000931.SZ)公告，公司下属公司北京华素制药股份有限公司(简称：北京华素) 于近日收到国家药品监督管理局签发的《受理通知书》，盐酸羟考酮缓释片(规格：10mg)上市许可申请 获得受理。 公告显示，盐酸羟考酮缓释片临床上用于治疗严重到需要长期持续、每天按时使用阿片类药物治疗、且 替代治疗不能充分缓解的疼痛。盐酸羟考酮是一种纯阿片受体激动剂，对μ受体具有相对的选择性，在 更高剂量时也能与其它阿片受体结合;羟考酮的主要治疗作用为镇痛。 ...

关于下属公司北京华素盐酸羟考酮缓释片（10mg）收到国家药品监督管理局《受理通知书》的公告 共 2 页 证券代码：000931 证券简称：中关村 公告编号：2025-142 北京中关村科技发展（控股）股份有限公司 关于下属公司北京华素盐酸羟考酮缓释片（10mg）收到国 家药品监督管理局《受理通知书》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京中关村科技发展（控股）股份有限公司（以下简称：公司）下属公司 北京华素制药股份有限公司（以下简称：北京华素）于近日收到国家药品监督 管理局（以下简称：国家药监局）签发的《受理通知书》，盐酸羟考酮缓释片 （规格：10mg）上市许可申请获得受理，现将相关情况公告如下： 剂型：片剂 规格：10mg 申请事项：境内生产药品注册上市许可 注册分类：化学药品 4 类 申请人：北京华素制药股份有限公司 受理号：CYHS2504326 结论：经审查，决定予以受理。 二、药品其他相关情况 一、基本信息 药品名称：盐酸羟考酮缓释片 关于下属公司北京华素盐酸羟考酮缓释片（10mg）收到国家药品监督管理局《受理通知书》的公告 共 ...